A/Prof Natalie Hannan

Find out more about Natalie Hannan's experience

Natalie Hannan's highlights

FEATURED Journal article

LOX-1 EXPRESSION IS REDUCED IN PLACENTA FROM CASES OF PREECLAMPSIA AND IN HYPOXIC CYTOTROPHOBLASTS

Natalie Hannan's selected work

SYSTEMATIC SCREENING APPROACH TO IDENTIFY NEW THERAPEUTICS FOR PREECLAMPSIA
Research Grant
Hey dad, your health affects your baby's well-being too
NEWS ARTICLE
ELEVATED CIRCULATING AND PLACENTAL SPINT2 IS ASSOCIATED WITH PLACENTAL INSUFFICIENCY
Journal article
FROM PATHOGENESIS TO THERAPEUTICS: TARGETING TWO SIGNALLING PATHWAYS AS A THERAPEUTIC STRA..
Research Grant
Analysis of mitochondrial regulatory transcripts in publicly available datasets with valid..
Journal article
NEW GENERATION ANTIPLATELET THERAPY TO PREVENT PREECLAMPSIA
Research Grant

Natalie Hannan's selected work

SYSTEMATIC SCREENING APPROACH TO IDENTIFY NEW THERAPEUTICS FOR PREECLAMPSIA

Research Grant

Hey dad, your health affects your baby's well-being too

NEWS ARTICLE

ELEVATED CIRCULATING AND PLACENTAL SPINT2 IS ASSOCIATED WITH PLACENTAL INSUFFICIENCY

Journal article

FROM PATHOGENESIS TO THERAPEUTICS: TARGETING TWO SIGNALLING PATHWAYS AS A THERAPEUTIC STRA..

Research Grant

Analysis of mitochondrial regulatory transcripts in publicly available datasets with valid..

Journal article

NEW GENERATION ANTIPLATELET THERAPY TO PREVENT PREECLAMPSIA

Projects

Displaying the 10 most recent projects from 25 for Natalie Hannan.

Developing novel therapeutic strategies to reduce spontaneous pre-term birth

2020 - 2022

Active

Novel therapeutic agents to treat preeclampsia in obese mice models

2018 - 2021

Active

NANOMEDICINE TARGETED DELIVERY OF THERAPEUTICS TO THE PLACENTA TO TREAT PREECLAMPSIA

Preeclampsia, one of the most serious complications of pregnancy, affects around 3-8% of all pregnancies. Sadly, there is no treatment. We h..

2017 - 2021

Active

Single cell RNA sequencing of amniotic fluid: a novel approach to understanding fetal development

2020 - 2021

Active

DEVELOPMENT OF NOVEL THERAPEUTICS TO PREVENT OR TREAT PREECLAMPSIA

Preeclampsia, a major pregnancy complication, affects ~3-8% of pregnancies. There is no cure. We have developed new strategies to tackle the..

2018 - 2021

Active

Nanomedicine targeted delivery of therapeutics to prevent preterm birth

2019 - 2020

Completed

FROM PATHOGENESIS TO THERAPEUTICS: TARGETING TWO SIGNALLING PATHWAYS AS A THERAPEUTIC STRATEGY TO TREAT PREECLAMPSIA

Preeclampsia is a serious complication of pregnancy that claims the lives of thousands of mothers and babies each year. There is no efficaci..

2017 - 2020

Completed

Is elevated endothelin-1 a reliable marker of preeclampsia and fetal growth restriction

2019 - 2020

Completed

INVESTIGATING MECHANISMS OF PREECLAMPSIA AND DEVELOPING NOVEL THERAPEUTICS

2016 - 2020

Completed

NEW GENERATION ANTIPLATELET THERAPY TO PREVENT PREECLAMPSIA

Preeclampsia, a major complication of pregnancy, affects around 3-8% of pregnancies. Sadly, there is no way to prevent or delay disease. We ..

2017 - 2019

Completed

25

Projects

Project Types

21

Research Grant

3

Internal Research Grant

1

Research Contracts

Additional Information

Scholarly Works

Displaying the 10 most recent scholarly works from 208 for Natalie Hannan.

LOX-1 EXPRESSION IS REDUCED IN PLACENTA FROM CASES OF PREECLAMPSIA AND IN HYPOXIC CYTOTROPHOBLASTS

Natasha de Alwis, Sally Beard, Natalie Binder, Natasha Pritchard, Tu'uhevaha Kaitu'u-Lino, Susan Walker, Owen Stock, Katie Groom, Scott Petersen, Amanda Henry, Joanne Said, Sean Seeho, Stefan Kane, Stephen Tong, Natalie Hannan